SRx Health Solutions (SRXH)
XASE:SRXH
SRXH Stock Chart & Stats
$0.24
--
Market closed
$0.24
--
Day’s Range― - ―
52-Week Range$0.08 - $2.16
Previous CloseN/A
VolumeN/A
Average Volume (3M)695.52K
Market Cap
$40.74M
Enterprise Value$12.62M
Total Cash (Recent Filing)$13.06M
Total Debt (Recent Filing)$21.03M
Price to Earnings (P/E)―
Beta0.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding298,207,670
10 Day Avg. Volume504,141
30 Day Avg. Volume695,518
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)16.44
Price to Sales (P/S)1.02
P/FCF Ratio-0.61
Enterprise Value/Market Cap0.31
Enterprise Value/Revenue-0.96
Enterprise Value/Gross Profit-4.78
Enterprise Value/Ebitda-0.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Near-term Liquidity InfusionThe March 2026 Series B initial closing delivered a material cash infusion, increasing runway and reducing immediate financing pressure. That durable liquidity support allows management to execute remediation steps and operations over coming months without relying exclusively on urgent capital markets access.
Simplified Capital StructureRedeeming Series A preferred eliminated a complex senior instrument and canceled ~125M as-converted common shares, materially reducing conversion overhang. A simpler capital structure improves long-term financial flexibility and reduces uncertainty for strategic planning and potential future equity actions.
Listing Remediation AcceptanceNYSE acceptance of a remediation plan stabilizes listing status and grants a defined timeframe to restore stockholders' equity. This structural breathing room reduces immediate delisting risk and gives management a multi-quarter horizon to execute balance-sheet repairs and communicate progress to stakeholders.
Bears Say
Persistent Cash BurnConsistent negative operating and free cash flow across recent periods signals that core operations do not self-fund growth. Continued cash burn forces reliance on external financing, increasing dilution risk and constraining the company's ability to invest in durable initiatives without recurring capital raises.
High Leverage And Weak Equity BaseExtremely elevated debt-to-equity and prior periods of negative equity indicate a thin capital cushion and elevated solvency risk. High leverage limits strategic options, raises interest and covenant risk, and makes the company more vulnerable to revenue volatility or financing market stress over the medium term.
Dilution And Governance/compliance RiskFrequent convertible/preferred financings create chronic dilution and complex investor rights, undermining common equity value over time. The NYSE warning on improper share issuances highlights governance and compliance weaknesses that could lead to regulatory actions and further impair capital-raising ability.
SRx Health Solutions News
SRXH FAQ
What was SRx Health Solutions’s price range in the past 12 months?
SRx Health Solutions lowest stock price was $0.08 and its highest was $2.16 in the past 12 months.
What is SRx Health Solutions’s market cap?
SRx Health Solutions’s market cap is $40.74M.
When is SRx Health Solutions’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SRx Health Solutions’s earnings last quarter?
Currently, no data Available
Is SRx Health Solutions overvalued?
According to Wall Street analysts SRx Health Solutions’s price is currently Overvalued.
Does SRx Health Solutions pay dividends?
SRx Health Solutions does not currently pay dividends.
What is SRx Health Solutions’s EPS estimate?
SRx Health Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SRx Health Solutions have?
SRx Health Solutions has 298,207,670 shares outstanding.
What happened to SRx Health Solutions’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SRx Health Solutions?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SRx Health Solutions Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.80%
12-Months-Change
Fundamentals
Return on Equity
435.85%
Trailing 12-Months
Asset Growth
76.96%
Trailing 12-Months
Company Description
SRx Health Solutions
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians.
Technical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
0.12% Insiders
0.07% Mutual Funds
0.02% Other Institutional Investors
99.75% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---